Powerful New Fragment Screening Technology CEfrag™ Screen
- About Selcia
- News & Events
- Contact Us
The CEfrag Screen is a new technique for fragment-based screening. It uses capillary electrophoresis (CE) to detect weak binding interactions between your target and low molecular weight compounds (fragments). The technique is available to clients on a fee-for-service basis as a primary or orthogonal screening tool for rapid hit identification on your target. This robust, proven technology allows you to cost effectively kick-start your drug discovery project or to complement and strengthen your in-house hit generation programs.
We offer the options of running a fragment screening campaign on your target using our own fragment library, or of using your library or any commercial fragment collection.
Please contact us for further information. We will be pleased to arrange a teleconference or meeting with our technical experts.